Skip to main content
. Author manuscript; available in PMC: 2022 May 24.
Published in final edited form as: Eur Respir J. 2018 Nov 15;52(5):1801467. doi: 10.1183/13993003.01467-2018

Figure 1. Study outline for both cohorts.

Figure 1.

A. In cohort 1, of 137 subjects recruited at the time of acute PE diagnosis, 102 subjects could be evaluated, 29 (28.4%) of whom had RPVO of at least 10%. B. In cohort 2, of the 185 subjects recruited after long-term treatment for acute PE, 182 subjects could be evaluated, 46 (25.3%) of whom developed RPVO of at least 10%.